Skip to content
Search

Latest Stories

Opioid overdose: Pharmacy professionals to be able to supply naloxone without a prescription

Opioid overdose: Pharmacy professionals to be able to supply naloxone without a prescription

DHSC also publishes a new 10-year strategic plan to expand and improve the drug and alcohol workforce

The UK government has announced plans to update legislation to enable more services and individuals to provide take-home supplies of naloxone – a life-saving opioid overdose antidote - over the next few weeks.

Naloxone can immediately reverse the effects of an opioid overdose by reversing breathing difficulties. The medicine can be administered by anyone in an emergency. However, current legislation allows only drug and alcohol treatment services to supply it without a prescription to individuals for future use.


The Department of Health and Social Care (DHSC) confirmed on Tuesday (14 May) that more professionals, including nurses, paramedics, police officers, probation officers and pharmacy professionals, will be able to supply the medicine without a prescription to save lives.

Health and Social Care Secretary Victoria Atkins warned that opioid addiction can ruin lives and it accounts for the largest proportion of drug-related deaths across the UK.

“We are working hard to reduce those numbers by expanding access to naloxone to save the lives of the most vulnerable,” she said.

The UK government is aiming to prevent nearly 1,000 drug-related deaths in England by the end of 2025.

The decision to widen access to take-home naloxone follows two government consultations conducted in 2021 and 2024, respectively.

“As a result of the overwhelming support, we are proceeding with the proposed legislative changes during spring 2024,” the government said in its response to the latest consultation, also published on Tuesday.

Additionally, the government has released a new 10-year strategic plan to expand and improve the drug and alcohol treatment and recovery workforce.

Key milestones outlined included recruiting more new and experienced professionals into the sector and developing better training for roles that are presently unregulated, such as drug and alcohol workers.

Developed by the Office for Health Improvement and Disparities (OHID) and NHS England, the new workforce plan builds on the progress of the government’s previous 10-year strategy to combat illicit drug use and reduce drug deaths.

As part of the strategy, an additional £532 million is being invested between 2022 and 2025 to improve the capacity and quality of drug and alcohol treatment. More than 3,900 additional staff have been recruited thus far through this funding.

The Health Secretary noted that the 10-year workforce plan will expand and boost the training of the next generation of drug and alcohol workers to improve services and support people to get their lives back on track.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less